Effects of <i>SLCO1B1</i> and <i>SLCO1B3</i> Genetic Polymorphisms on Valsartan Pharmacokinetics in Healthy Korean Volunteers
<b>Purpose:</b> This study aimed to examine OATP1B1 (<i>SLCO1B1</i>) and OATP1B3 (<i>SLCO1B3</i>) on the pharmacokinetics of valsartan. Twenty-five subjects were genotyped for 16 single-nucleotide polymorphisms of the <i>SLCO1B1</i> and <i>SLCO1B...
Main Authors: | Gonjin Song, Jee-Eun Chung, Jeong Yee, Kyung-Eun Lee, Kyungsoo Park, Hye-Sun Gwak |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/11/9/862 |
Similar Items
-
SLCO1B1 Phenotype and CYP3A5 Polymorphism Significantly Affect Atorvastatin Bioavailability
by: Pablo Zubiaur, et al.
Published: (2021-03-01) -
Influence of <it>SLCO1B1 </it>and <it>CYP2C8 </it>gene polymorphisms on rosiglitazone pharmacokinetics in healthy volunteers
by: Aquilante Christina L, et al.
Published: (2008-09-01) -
THE SLCO1B1 GENE POLYMORPHISM AND STATIN-INDUCED MYOPATHY IN RUSSIAN PATIENTS
by: V. I. Petrov, et al.
Published: (2014-10-01) -
APPLIED ASPECTS OF SLCO1B1 PHARMACOGENETIC TESTING FOR PREDICTING OF STATIN-INDUCED MYOPATHY AND PERSONALIZATION OF STATINS THERAPY
by: D. A. Sychev, et al.
Published: (2015-09-01) -
APPLIED ASPECTS OF SLCO1B1 PHARMACOGENETIC TESTING FOR PREDICTING OF STATIN-INDUCED MYOPATHY AND PERSONALIZATION OF STATINS THERAPY
by: D. A. Sychev, et al.
Published: (2015-09-01)